Pluvicto Injection, Solution
Product Images NDC 0078-1217

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pluvicto (NDC 0078-1217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure Of Lutetium (Pluvicto 01)

Chemical Structure Of Lutetium (Pluvicto 01)
FDA Label Image

Figure 1. Kaplan-meier Plot Of Radiographic Progression-free Survival In Psmafore (Pluvicto 02)

Figure 1. Kaplan-meier Plot Of Radiographic Progression-free Survival In Psmafore (Pluvicto 02)
FDA Label Image

Figure 2. Kaplan-meier Plot Of Overall Survival In Vision (Pluvicto 03)

Figure 2. Kaplan-meier Plot Of Overall Survival In Vision (Pluvicto 03)
FDA Label Image

Principal Display Panel Pluvicto® 1,000 Mbq/ml (27 Mci/ml) Lutetium Lu 177 Vipivotide Tetraxetan Injection Intravenous Use Single-dose Vial Sterile Ndc# 0078-1217-61 Rx Only Novartis (Pluvicto 04)

Principal Display Panel Pluvicto® 1,000 Mbq/ml (27 Mci/ml) Lutetium Lu 177 Vipivotide Tetraxetan Injection Intravenous Use Single-dose Vial Sterile Ndc# 0078-1217-61 Rx Only Novartis (Pluvicto 04)